Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature

  • Authors:
    • Soňa Kontseková
    • Anna Ohradanova Repic
    • Katarína Polčicová
    • Pauliina Tuomaala
    • Jaromír Pastorek
    • Silvia Pastoreková
    • Seppo Parkkila
    • Monika Baráthová
  • View Affiliations

  • Published online on: July 23, 2012     https://doi.org/10.3892/ijo.2012.1566
  • Pages: 1365-1372
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endosialin, alternatively named tumor endothelial marker or CD248, was originally discovered as an antigen selectively expressed in tumor blood vessels. Subsequent studies showed that it is confined to stromal fibroblasts and pericytes of tumor vasculature rather than to tumor endothelium. Endosialin levels are upregulated in different tumor types including those derived from the brain, colon and breast. Expression of endosialin is associated with tumor growth, progression and correlates with a pro-proliferative and pro-migratory phenotype. However, the function of endosialin and mechanisms of its regulation are still incompletely understood. To facilitate further study of endosialin in angiogenesis, its interaction with the potential binding partners and other aspects of endosialin function, we generated six new domain-specific anti-endosialin monoclonal antibodies. Two of them recognize the C-type lectin-like domain-Sushi/SCR/CCP and four antibodies are directed to the sialomucin domain. The antibodies are suitable for various immunodetection methods including immunoblotting and immunohistochemistry. They represent important tools for improving our understanding of endosialin regulation, biological role and contribution of its extracellular domains to the tumor phenotype.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 41 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kontseková S, Ohradanova Repic A, Polčicová K, Tuomaala P, Pastorek J, Pastoreková S, Parkkila S and Baráthová M: Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature. Int J Oncol 41: 1365-1372, 2012
APA
Kontseková, S., Ohradanova Repic, A., Polčicová, K., Tuomaala, P., Pastorek, J., Pastoreková, S. ... Baráthová, M. (2012). Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature. International Journal of Oncology, 41, 1365-1372. https://doi.org/10.3892/ijo.2012.1566
MLA
Kontseková, S., Ohradanova Repic, A., Polčicová, K., Tuomaala, P., Pastorek, J., Pastoreková, S., Parkkila, S., Baráthová, M."Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature". International Journal of Oncology 41.4 (2012): 1365-1372.
Chicago
Kontseková, S., Ohradanova Repic, A., Polčicová, K., Tuomaala, P., Pastorek, J., Pastoreková, S., Parkkila, S., Baráthová, M."Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature". International Journal of Oncology 41, no. 4 (2012): 1365-1372. https://doi.org/10.3892/ijo.2012.1566